Profil

Coppée Frédérique

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Biochimie métabolique et moléculaire

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Biochimie métabolique et moléculaire

ORCID
0000-0002-4791-8279

Main Research Fields
Biotechnology
General & internal medicine
Zoology
Biochemistry, biophysics & molecular biology
Immunology & infectious disease
Main Keywords
insulin; adiponectin; cardiovascular diseases; PCSK9; FSHD;
Main Unit & Research Centers
CREMH - Mind & Health
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale
UMHAP - Centre de Recherche UMONS-Ambroise Paré
CIPSE - Centre de recherche interdisciplinaire en Psychophysiologie et Electrophysiologie de la cognition
Main Co-authors
Belayew, Alexandra 
Ansseau, Eugénie 
Tassin, Alexandra 
Laoudj-Chenivesse, Dalila

Publications (total 170)

The most downloaded
13 downloads
LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). Towards a muscle-targeted delivery of antisense agents against DUX4. Poster session presented at The 29th FSHD Society's annual International Research Congress 2022. https://hdl.handle.net/20.500.12907/43132
The most cited
1550 citations (Scopus®)
Lechien, J., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., Chekkoury-Idrissi, Y., Hans, S., Lopez-Delgado, I., Calvo-Henriquez, C., Lavigne, P., Falanga, C., Barillari, M. R., Cammaroto, G., Khalife, M., & Saussez, S. (04 June 2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology, Apr 6, 1-11. doi:10.1007/s00405-020-05965-1 https://hdl.handle.net/20.500.12907/23131

Tchéoubi, S. E. R., Akpovi, C. D., Coppée, F., Decleves, A.-E., Laurent, S., Agbangla, C., & Burtea, C. (November 2022). Molecular and cellular biology of PCSK9: impact on glucose homeostasis. Journal of Drug Targeting, 30 (9), 948 - 960. doi:10.1080/1061186X.2022.2092622
Peer Reviewed verified by ORBi

Tchéoubi, E. S. R., Akpovi, C. D., Coppée, F., Tassin, A., Decleves, A.-E., Fiogbé, S. E., Sègbo, G. J., Laurent, S., & Burtea, C. (11 September 2022). PCSK9 variants affect differently the risk of type 2 diabetes mellitus development. Potential impact on the therapy with PCSK9 inhibitors. Poster session presented at 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis.
Peer reviewed

LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). Towards a muscle-targeted delivery of antisense agents against DUX4. Poster session presented at The 29th FSHD Society's annual International Research Congress 2022.

Decarnoncle, M., Decroo, C., Coppée, F., Tassin, A., Tagliatti, V., Villers, A., Colet, J.-M., Nonclercq, D., Legrand, A., Ris, L., Wattiez, R., & Decleves, A.-E. (25 November 2021). Développement d'une trousse de dosage d'organokines par spectrométrie de masse. Poster session presented at Networking EpiCURA-UMONS, Baudour, Belgium.

Pierre, L., Decarnoncle, M., Marlier, H., Coppée, F., Juszczak, F., & Decleves, A.-E. (25 November 2021). Plateforme Rein-Santé : Focus sur la cellule tubulaire proximale. Poster session presented at Networking EpiCURA-UMONS, Baudour, Belgium.

TCHEOUBI, S. E. R.* , AKPOVI, C. D.* , Coppée, F., Decleves, A.-E., FIOGBE, S. E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C.*. (06 September 2021). PCSK9 intronic variant rs142149050 is associated with low level of LDL-cholesterol and lower cardiovascular risk in type 2 diabetes. Paper presented at - 4ème Congrès international de la Société Africaine de Physiologie et Physiopathologie (SA2P), Cotonou, Benin.
Peer reviewed
* These authors have contributed equally to this work.

Tchéoubi, E. R. S., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C. (24 July 2020). A novel cholesterol-lowering PCSK9 variant is associated with low blood glucose level and lower cardiovascular risk in type 2 diabetes. Paper presented at 4th Global Summit on Diabetes and Endocrinology, Scientific Federation-Diabetes, Manchester, Unknown/unspecified.

Coppée, F., Lechien, J., Decleves, A.-E., Tafforeau, L., & Saussez, S. (01 July 2020). Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations. New Microbes and New Infections, 36, 100696. doi:10.1016/j.nmni.2020.100696
Peer Reviewed verified by ORBi

Claus, C., Salvin, M., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (25 June 2020). Determination of the major DUX4/4c partner: the multifunctional C1qBP protein. Poster session presented at FSHD Society International Research Congress, Washington , United States - District of Columbia.

Derenne, A., Tassin, A., Nguyen, T. H., DeRoeck, E., Jenart, V., Ansseau, E., Belayew, A., Coppée, F., Decleves, A.-E., & Legrand, A. (2020). Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics. Scientific Reports.
Peer reviewed

Lechien, J., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., Chekkoury-Idrissi, Y., Hans, S., Lopez-Delgado, I., Calvo-Henriquez, C., Lavigne, P., Falanga, C., Barillari, M. R., Cammaroto, G., Khalife, M., & Saussez, S. (04 June 2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology, Apr 6, 1-11. doi:10.1007/s00405-020-05965-1
Peer Reviewed verified by ORBi

Dudome, V., Genva, S., Coppée, F., & Decleves, A.-E. (31 January 2020). Mitochondrial dysfunction and oxidative stress response induced by palmitate in human muscle cells. Paper presented at 14 th meeting of the FRS-FNRS Contact Group on Oxidative Processes and Antioxidants, Mons, Belgium.

Dudome, V., Coppée, F., & Declèves, A.-E. (31 January 2020). Mitochondrial dysfunction and oxidative stress response induced by palmitate in human muscle cells. Paper presented at 14th meeting of the FRS-FNRS Contact group on Oxidative Proceses and Antioxidants, UMONS, Belgium.

Claus, C., Salvin, M., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (31 January 2020). Does the multifunctional protein C1qBP play a role in oxidative stress triggering in FSHD skeletal muscle cells? Poster session presented at Oxidative stress, redox regulation and cell fate, The FNRS contact Group: Oxidative Processes and Antioxidants, Umons, Mons, Belgium.

Claus, C., Salvin, M., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (30 January 2020). Does the multifunctional protein C1qBP play a role in the susceptibility of oxidative stress in the muscle dystrophy FSHD? Poster session presented at Oxidative stress, redox regulation and cell fate, Mons, Belgium.

Coppée, F. (2019). FSHD: d'un projet de thèse(s) à la rédaction d'un projet Européen (EJP-RD 2019).

TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., AGBANGLA, C., & Burtea, C. (16 September 2019). PCSK9 synonymous variant gln342=, insulin and adiponectin levels in type 2 diabetes mellitus patients. Paper presented at VIIème Colloques des sciences, cultures et technologies, Campus universitaire d'Abomey-Calavi, Benin.

Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (08 July 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology. Poster session presented at Advances in skeletal muscle biology in health and disease, Gainesville, United States.

Claus, C., & Coppée, F. (2019). FSH-Time 'Où en est la recherche ? '.

TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., & Burtea, C. (21 June 2019). Linking PCSK9 genetic variants with insulin impairment in type 2 diabetes mellitus patients. Paper presented at 2ème Journées Africaines d'Endocrinologie clinique, Abidjan, Côte d’Ivoire.

Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (21 June 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology. Poster session presented at Discovery Worflow Toolsfo Small Molecules and Biologics-Promega, Bruxelles, Belgium.

TCHEOUBI, S. E. R., Akpovi, C., Coppée, F., Decleves, A.-E., & Laurent, S. (05 June 2019). Linking PCSK9 genetic variants with insulin impairment in type 2 diabetes mellitus patients. Poster session presented at Congrès sur l'endocrinologie, Abidjan, Côte d’Ivoire.

Claus, C., Dudome, V., Derenne, A., Coppée, F., & Decleves, A.-E. (2019). Draw my phD.

Wauters, M., Vertraelen, P., Garcia-Diaz Barriga, G., Leroy, B., Delporte, C., Coppée, F., Van Antwerpen, P., Wattiez, R., De Vos, W., & Ris, L. (24 May 2019). Toxicity assessment of the hyperphosphorylated Tau protein on the neuronal network connectivity. Paper presented at 13th National Congress of the Belgian Society for Neuroscience, Brussels, Belgium.

Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (17 May 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology. Poster session presented at Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium.

TCHEOUBI, S. E. R., Coppée, F., Decleves, A.-E., Laurent, S., AKPOVI, C. D., & Burtea, C. (17 May 2019). PCSK9 gene variants in west - African type 2 diabetes mellitus (T2DM) patients. Poster session presented at Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium.

Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (03 May 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology. Poster session presented at Mardi de la Recherche - UMONS - FWEG, Mons, Belgium.

Dudome, V., Coppée, F., Decleves, A.-E., & Dabauvalle, M. C. (29 April 2019). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells. Poster session presented at 26th European Congress on Obesity, Glasgow, Unknown/unspecified.

Nguyen, T. H., Derenne, A., Ansseau, E., De Roeck, E., Coppée, F., Decleves, A.-E., Tassin, A., & Legrand, A. (27 March 2019). Development of easy outcome measures for the in vivo screening of therapeutical agents targeting DUX4 in FSHD. Poster session presented at MYOLOGY, Bordeaux, France.

Derenne, A., Kouakou, C., Belayew, A., Decleves, A.-E., Tassin, A., Burtea, C., & Coppée, F. (08 March 2019). Development of peptides for specific skeletal muscle targeted drug delivery. Poster session presented at 2019 Advances in Skeletal Muscle Biology in Health and Disease, University of Florida, United States - Florida.

Dudome, V., Coppée, F., Decleves, A.-E., & Dabauvalle, M. C. (13 January 2019). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells'. Poster session presented at Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium.

Dudome, V., Coppée, F., & Decleves, A.-E. (31 October 2018). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells. Poster session presented at 7th European worshop on lipid mediators, Bruxelles, Belgium.

Claus, C., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (20 September 2018). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the pathology FSHD. Poster session presented at Structural Dynamics In Cellular Communication, Bruxelles, Belgium.

Wauters, M., Leroy, B., Coppée, F., & Ris, L. (13 August 2018). Internalisation and toxic effects resulting from the addition of extracellular hyperphosphorylated monomeric Tau. Paper presented at Belgian Brain Congress 2018-Belgian Brain Council, Liège, Belgium.

Wauters, M., Coppée, F., & Ris, L. (10 July 2018). A role for hyperphosphorylated monomeric Tau in the propagation of Tau pathology. Paper presented at 11th FENS Forum of Neuroscience, Berlin, Germany.

Claus, C., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (08 June 2018). Direct interaction of DUX4/4c with the multifunctional protein C1QBP. Poster session presented at FSH International Research Congress, Las Vegas, United States - Nevada.

Dudome, V., Coppée, F., & Declèves, A.-E. (18 February 2018). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells. Poster session presented at Scientific Meeting FNRS Contact Group 'Oxidative Processes and Antioxidants', Namur, Belgium.

Vanderplanck, C., Tassin, A., Ansseau, E., Charron, S., Wauters, A., Lancelot, C., Vancutsem, K., Laoudj Chevinesse, D., Belayew, A., & Coppée, F. (12 January 2018). 'Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei'. Skeletal Muscle, 8 (2). doi:10.1186/s13395-017-0148-4
Peer reviewed

Ansseau, E., Sciot, M., Goudji, C., Castella, S., Larcher, J.-C., Belayew, A., & Coppée, F. (2017). FSHD and OPMD: Deregulation of IGF2BP1-mRNP components during the differentiation of FSHD muscle cells. Paper presented at 22nd International Congress of the Word Muscle Society, Saint Malo, France.

Derenne, A., Tassin, A., Burtea, C., Decleves, A.-E., & Coppée, F. (13 September 2017). Development of specific molecules using the phage display technology allowing a targeted drug delivery to skeletal muscles in the aim to treat muscular disorders.». Paper presented at Journée PhD day EDT en Sciences Pharmaceutiques, Liège, Belgium.

Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Decleves, A.-E., & Legrand, A. (11 May 2017). DUX4 surexpression and silencing in a murine model. Poster session presented at Interuniversity PhD student, Liège, Belgium.

Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Belayew, A., Decleves, A.-E., & Legrand, A. (07 March 2017). DUX4 surexpression and silencing in a murine model. Poster session presented at Mardi des Chercheurs (MdC2017), Mons, Belgium.

Ansseau, E., Vanderplanck, C., Wauters, A., Harper, S. Q., Coppée, F., & Belayew, A. (03 March 2017). Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes, 8 (3), 93. doi:10.3390/genes8030093
Peer Reviewed verified by ORBi

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (16 November 2016). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD). Poster session presented at Bioforum, Liège Ulg , Unknown/unspecified.

Ansseau, E., Lancelot, C., Wauters, A., Vanderplanck, C., Belayew, A., & Coppée, F. (10 November 2016). Transcription factors DUX4 and DUX4c associate with mRNP granules in the cytoplasm of fusing myoblasts: a new function in translation regulation? Poster session presented at FSH Society, Boston, United States - Massachusetts.

Ansseau, E., Lancelot, C., Belayew, A., & Coppée, F. (04 October 2016). Transcription factors DUX4 and DUX4c associate with mRNP granules in the cytoplasm of fusing myoblasts: a new function in translation regulation? Poster session presented at 21st International WMS Congress, Granada, Spain.

P, D., Kiseleva, E., Kharchenko, O., Ivashkin, E., Pichugin, A., Dessen, P., Robert, T., Coppée, F., Belayew, A., Camac, G., Laoudj Chevinesse, D., Lipinski, M., Vasiliev, A., & Vassetzky, Y. (04 October 2016). Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis. Oncotarget, 7 (40), 65090-65108. doi:10.18632/oncotarget.11368
Peer reviewed

Coppée, F. (17 June 2016). New Insights in FSHD. Paper presented at Algemeen Ziekenhuis Sint-Jan, Bruges, Belgium.

Ansseau, E., O, J., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj Chevinesse, D., Wattiez, R., Harper, S., Belayew, A., & Coppée, F. (14 March 2016). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules. Poster session presented at International Congress Of Myology, Lyon, France.

De La Kethulle De Ryove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton, S., Coppée, F., Lagneaux, L., & Belayew, A. (14 March 2016). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Poster session presented at 5th International Congress of Myology, Lyon, France.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (14 March 2016). 'Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy.'. Poster session presented at 5th International Congress of Myology, Lyon, France.

Ansseau, E., Eidal, J., Lancelot, C., Tassin, A., Matteotti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (2016). Homologous transcription factors DUX4 and DUX4c associate with cytoplasmic proteins during muscle differentiation. PLoS ONE.
Peer reviewed

Ansseau, E., & Coppée, F. (18 January 2016). « Homologous DUX transcription factors interact with cytoplasmic proteins during muscle differentiation. Paper presented at Séminaires de l'institut de Myologie, Paris, France.

Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (06 October 2015). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules. Paper presented at FSH society, Boston, United States - Massachusetts.

De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (06 October 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Paper presented at FSH Society, Boston, United States - Massachusetts.

Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (04 October 2015). Unexpected location of DUX4/4c transcription factors in the cytoplasm suggests a role in mRNP granules and translation regulation. Poster session presented at International World Muscle Society Congress, Brighton, United Kingdom.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy. Paper presented at International World Muscle Society congress, Brighton, United Kingdom.

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (23 September 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD). Poster session presented at EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified.

Lancelot, C., Mascolo, C., Nonclercq, D., Carnac, G., Laoudj-Chenivesse, D., Coppée, F., & Belayew, A. (22 September 2015). How does fibrosis in FSHD muscle contribute to the lack of muscle regeneration ? Poster session presented at EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified.

De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (20 July 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Stem Cells and Development, 24 (22), 2674-86. doi:10.1089/scd.2014.0575
Peer Reviewed verified by ORBi

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (22 May 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy. Poster session presented at Journée UMHAP from lab to bedside, Mons, Belgium.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (17 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of facioscapulohumeral muscular dystrophy (FSHD. Poster session presented at Novel Therapies for monogennic diseases, Paris, France.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (15 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy. Poster session presented at symposium de thérapie génique du Collège de France, Paris, France.

Coppée, F. (04 April 2015). La double vie de DUX4 et DUX4c. Paper presented at AMIS FSH - Rencontre de printemps, Mons, Belgium.

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (10 March 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD). Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (10 March 2015). Membrane proteins : putative FSHD biomarkers. Poster session presented at 8ème édition de la Matinée de Chercheurs, Mons, Belgium.

De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (11 February 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Poster session presented at Télévie's Research Seminar, ULB-Erasme, Belgium.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (19 October 2014). Membrane proteins: putative FSHD biomarkers? Poster session presented at FSH Society international research consortium and research planning meeting, San Diego, United States - California.

Ansseau, E., Matteoti, C., Tassin, A., Lancelot, C., Leroy, B., Hubeau, C., Nachtegael, C., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Meyer, P., Carnac, G., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (17 October 2014). Unexpected role for DUX transcription factors into the cytoplasm. Paper presented at International Research Consortium & Research Planning Meetings, San Diego, United States - California.

Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Carnac, G., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (17 October 2014). WNT pathway alterations in FSHD. Poster session presented at FSH Society international research consortium and research planning meeting, San Diego, United States - California.

Derenne, A., Tassin, A., Conotte, S., Coppée, F., Belayew, A., & Legrand, A. (17 October 2014). Comparison of two methods of naked DNA delivery in mice: which one is the most appropriate in the FSHD context? Poster session presented at FSH Society international research consortium and research planning meeting, San Diego, United States - California.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Coppée, F., Wattiez, R., & Belayew, A. (08 July 2014). Membrane proteins : putative FSHD biomarkers? Poster session presented at ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France.

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (08 July 2014). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD). Poster session presented at ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France.

Lancelot, C., Ansseau, E., Tassin, A., Matteoti, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (06 July 2014). Study of the double homeodomain DUX protein partners: focus on the interaction with desmin. Paper presented at IF-NMD Workshop Nice 2014 - Satellite Workshop to ICNMD, Nice, France.

Tassin, A., Ansseau, E., Matteotti, C., Lancelot, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (14 May 2014). Study of the double homeodomain DUX protein partners highlights DUX4c involvement in human muscle regeneration. Paper presented at EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy.

Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (14 May 2014). WNT pathway alterations in FSHD. Poster session presented at EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy.

De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (2014). DUX4 expression during Osteogenic Differentiation in MSCs. Paper presented at 20th ISCT Annual Meeting (International Society Cellular Therapy) 2014, Palais des Congrès, Paris, France.

De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (25 April 2014). DUX4 expression during Osteogenic Differentiation in MSCs. Poster session presented at 20th ISCT Annual Meeting (International Society Cellular Therapy) 2014, Palais des Congrès, Paris, France.

De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (05 December 2013). DUX4 expression during Osteogenic Differentiation in MSCs. Poster session presented at Journée des jeunes chercheurs Télévie, Université Catholique de Louvain, Belgium.

Lancelot, C., Carnac, G., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (28 November 2013). Development of fibrosis and its impact on muscle regeneration in FSHD muscle. Poster session presented at 11ème Journées de la Société Française de Myologie, Montpellier, France.

Vanderplanck, C., Tassin, A., Lancelot, C., Ansseau, E., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (27 November 2013). DUX4c, a DUX4-homologue, causes the FSHD disorganized myotube phenotype: an additional target for therapeutic strategies. Paper presented at Colloque Myogenèse XVI, Montpellier, France.

Ansseau, E., Charron, S., Laoudj-Chenivesse, D., Coppée, F., & Belayew, A. (21 October 2013). Interplay between Sp1, YY1 and MYOD in transcription regulation of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD). Paper presented at FSH Society (FacioScapuloHumeral Muscular Dystrophy) International Reasearch Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts.

De La Kethulle De Ryhove, L., Ansseau, E., Coppée, F., & Belayew, A. (06 June 2013). DUX4 expression in embryonic stem cells. Poster session presented at 3rd Heidelberg forum for young life scientists, DFKZ, Heidelberg, Germany.

Tassin, A., Vanderplanck, C., Ansseau, E., Derenne, A., Coppée, F., & Belayew, A. (24 May 2013). Different approaches to evaluate antisense strategies against the causal gene of the FSHD myopathy. Poster session presented at Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium.

Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (24 May 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA. Poster session presented at Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (24 May 2013). Caveolar proteins: putative FSHD biomarkers? Poster session presented at 1st Health Institute Day, Mons, Belgium.

Lancelot, C., Carnac, G., Nonclercq, D., Delrée, P., Coppée, F., & Belayew, A. (23 May 2013). Development of fibrosis and its impact on muscle regeneration in FSHD muscle. Poster session presented at Journée de l'institut santé, Mons, Belgium.

Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (22 April 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD. Paper presented at MDA Scientific Conference, Washington DC, United States - District of Columbia.

De La Kethulle De Ryhove, L., Ansseau, E., Coppée, F., & Belayew, A. (12 March 2013). Study of DUX4 expression and function in non-muscular cells. Poster session presented at 7ème édition de la Matinée de Chercheurs, Mons, Belgium.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (29 January 2013). Caveolar proteins: putative FSHD biomarkers? Poster session presented at ', Journée de l'école doctorale en sciences biomédicales et pharmaceutiques, UMONS, Mons, Belgium.

Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (01 January 2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? Journal of Cellular Molecular Medecine, 17 (1), 1-15. doi:10.1111/j.1582-4934.2012.01647.x
Peer reviewed

Tassin, A., Leroy, B., Laoudj-Chenivesse, D., Wauters, A., Vanderplanck, C., Le Bihan, M.-C., Coppée, F., Wattiez, R., & Belayew, A. (18 December 2012). FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes. PLoS ONE, 7 (12), 51865. doi:10.1371/journal.pone.0051865
Peer reviewed

De La Kethulle De Ryhove, L., Dimitrova, J., Ansseau, E., Geens, M., Lagneaux, L., Sermon, K., Coppée, F., & Belayew, A. (10 December 2012). DUX4 expression in non-muscle cells. Poster session presented at Télévie 2013, Liège, Belgium.

Tassin, A., Vanderplanck, C., Leroy, B., Charron, S., Ansseau, E., Wauters, A., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (07 November 2012). Investigations on the FSHD disorganized myotube phenotype. Poster session presented at FSH Society International Reasearch Consortium Meeting, San Francisco, United States.

Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (06 November 2012). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD. Paper presented at FSH Society International Reasearch Consortium Meeting, San Francisco, United States.

Charron, S., Vanderplanck, C., Vancutsem, K., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (25 September 2012). Facioscapulohumeral dystrophy: focus on the WNT perturbation. Poster session presented at EMBO Meeting, Nice, France.

Charron, S., Belayew, A., & Coppée, F. (29 November 2011). WNT et FOXO dans la FSHD. Paper presented at Merci Téléthon, Forchie-la-marche, Belgium.

Richards, M., Coppée, F., Thomas, N., Belayew, A., & Upadhyaya, M. (2011). Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Human Genetics. doi:10.1007/s00439-011-1100-z

Ansseau, E., Mattéotti, C., Gerbaux, C., Yip, C., Pire, E., Vachaudez, V., Cloet, S., Wattiez, R., Coppée, F., & Belayew, A. (07 November 2011). DUX4 and DUX4c protein partners in muscle cells. Poster session presented at FSH Society (FSHD) 2011 International Research Consortium and Researchplanning meetings, Boston, United States - Massachusetts.

Charron, S., Vanderplanck, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (07 November 2011). Perturbation of the WNT signaling pathway in FSHD. Paper presented at FSH Society (FSHD) 2011 International Research Consortium and Researchplanning meetings, Boston, United States - Massachusetts.

Tassin, A., Laoudj-Chenivesse, D., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (07 November 2011). Detection of endogenous DUX4 protein in FSHD muscles: could the spreading of a rare protein cause FSHD? Poster session presented at FSH Society International Research Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts.

Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (01 November 2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression and corrected by its suppression. PLoS ONE, 6 (10), 26820. doi:10.1371/journal.pone.0026820
Peer reviewed

Charron, S., Belayew, A., & Coppée, F. (29 October 2011). La signalisation cellulaire WNT et FOXO. Paper presented at Assemblée générale de l'association Amis FSH Europe, Agde, France.

Dmitriev, P., Petrov, A., Ansseau, E., Stankevicins, L., Charron, S., Kim, E., Bos, T., Robert, T., Turki, A., Coppée, F., Belayew, A., Lazar, V., Carnac, G., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (21 September 2011). The Kruppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy. Journal of Biological Chemistry, 286, 44620-44631.
Peer Reviewed verified by ORBi

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Vanderplanck, C., Wauters, A., Turky, D., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (12 May 2011). The galectin-1 gene is activated in FSHD Myotubes as a result of the DUX4 transcriptional deregulation cascade. Poster session presented at 4th international congress of myology 2011, Lille , France.

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (12 May 2011). Interfering with the transcription deregulation cascades in fshd. Paper presented at 4th international congress of myology 2011, Lille , France.

Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (12 May 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD). Poster session presented at 4th international congress of myology 2011, Lille , France.

Vanderplanck, C., Ansseau, E., Charron, S., Tassin, A., Turki, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (06 May 2011). SUPPRESSION OF DUX4 OR DUX4C EXPRESSION BY ANTISENSE STRATEGIES IN A THERAPEUTIC APPROACH FOR FSHD. Paper presented at 7th AGTS Meeting, Melbourne, Australia.

Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (22 March 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD). Poster session presented at La matinée des chercheurs, Mons, Unknown/unspecified.

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (14 March 2011). Suppression of DUX4 or DUX4c protein expression by antisense strategies in a therapeutic approach for FSHD. Paper presented at MDA national scientific conference Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace, Las Vegas, United States - Nevada.

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (25 November 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry. Poster session presented at VIIIè journées annuelles Société Française de Myologie, Nice, France.

Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppée, F., Ladner, K., Guttridge, D., Yang, J., & Harper, S. Q. (02 November 2010). DUX4 over-expression recapitulates FSHD-associated phenotypes in vivo. Paper presented at American Society of Human Genetics, 2010 Annual Meeting, Washington DC, United States - District of Columbia.

Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppée, F., Ladner, K. J., Guttridge, D., Yang, J., & Harper, S. Q. (2010). DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Annals of Neurology. doi:10.1002/ana.22275
Peer Reviewed verified by ORBi

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Charron, S., Coppée, F., Wattiez, R., & Belayew, A. (25 October 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry. Poster session presented at FSHD International Research Consortium Meeting, Boston, United States - Massachusetts.

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (21 October 2010). Suppression of DUX4 or DUX4c protein expression by antisense strategies as a therapeutic approach for FSHD. Paper presented at FSH Society International Research Consortium & Research Planning Meeting, Boston, United States - Massachusetts.

Vanderplanck, C., Ansseau, E., Coppée, F., Belayew, A., & Wilton D., S. (01 September 2010). Agents useful in treating Facioscapulohumeral muscular dystrophy.

Tassin, A., Coppée, F., Leroy, B., Sauvage, S., Preillon, J., Erculisse, V., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (09 November 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures. Paper presented at FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts.

Dmitriev, P., Petrov, A., Ansseau, E., Charron, S., Coppée, F., Belayew, A., Carnac, G., Turki, A., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (06 November 2009). Kruppel-like factor KLF15 interacts with the D4Z4 enhancer and upregulates a FSHD-related gene DUX4c. Poster session presented at FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts.

Tassin, A., Charron, S., Vanderplanck, C., Coppée, F., & Belayew, A. (2009). Des techniques en 'omique' pour comprendre une maladie héréditaire des muscles.

Charron, S., Vanderplanck, C., Belayew, A., & Coppée, F. (17 October 2009). WNT and FOXO signaling pathways in FSHD. Poster session presented at Protein modifications in development and diseases, Liège, Belgium.

Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I., Mainfroid, V., Figlewicz, D., Mouly, V., Butler-Browne, G., Belayew, A., & Coppée, F. (01 October 2009). DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation. PLoS ONE, 4 (10), 7482. doi:10.1371/journal.pone.0007482
Peer reviewed

Capouillez, A., Debauve, G., Decaestecker, C., Filleul, O., Chevalier, D., Mortuaire, G., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (01 September 2009). The Helicase-Like Transcription Factor is a strong predictor of recurrence in Hypopharyngeal but not in Laryngeal squamous cell carcinomas. Histopathology, 55, 77-90.
Peer Reviewed verified by ORBi

Tassin, A., Coppée, F., Leroy, B., Erculisse, V., Sauvage, S., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (27 July 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures. Paper presented at International Symposium Signal transduction and disease, Aachen, Germany.

Dumonceaux, J., Marie, S., Ferry, A., Coppée, F., Belayew, A., Voit, T., & Butler-Browne, G. (2009). Dux4 over-expression in normal mouse: Generation of a mouse model with an FSHD phenotype? Paper presented at 14th International WMS Congress, Genève, Switzerland.

Aouay, A., Coppée, F., Cloet, S., Cuvelier, P., Belayew, A., Lagneau, P.-E., & Mullender, C. (01 November 2008). Molecular characterization of Prototheca strains isolated from bovine mastitis. Journal de Mycologie Médicale, 18, 224-227. doi:10.1016/j.mycmed.2008.10.002
Peer reviewed

Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T., Garner, H. R., Agha-Mohammadi, S., Tassin, A., Coppée, F., Belayew, A., Perlingeiro, R., & Kyba, M. (01 October 2008). An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO Journal, 27 (20), 2766-79.
Peer Reviewed verified by ORBi

Tassin, A., Vanderplanck, C., Ansseau, E., Marcowyzc, A., Barro, M., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (26 May 2008). Studies on the expression and function of DUX4c, a gene located close to the FSHD locus. Poster session presented at 3ème Congrès International de Myologie, Marseille, France.

Tassin, A., Ansseau, E., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (21 January 2008). DUX4 and DUX4c activate different pathways in Facioscapulohumeral dystrophy. Paper presented at Colloque « Myogenese IX », Institut de Myologie, Paris, France.

Tassin, A., Vanderplanck, C., Ansseau, E., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Dabauvalle, M. C., Wehnert, M., Chen, Y.-W., Belayew, A., & Coppée, F. (2008). Study of DUX4 and DUX4c in facioscapulohumeral muscular dystrophy. Paper presented at 13th International WMS Congress, Newcastle upon Tyne, United Kingdom.

Capouillez, A., Decaestecker, C., Filleul, O., Chevalier, D., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (01 January 2008). Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Archiv, 453 (5), 491-499.
Peer Reviewed verified by ORBi

Ansseau, E., Tassin, A., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (04 November 2007). Further studies on the DUX4, DUX4c and PITX1 genes in FSHD. Paper presented at FSHD international Workshop meeting, San Diego, United States - California.

Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Chen, Y.-W. (01 November 2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104 (46), 18157-18162. doi:10.1073/pnas.0708659104
Peer Reviewed verified by ORBi

Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Mattéotti, C., Arias, C., Corona, E. D., Nuñez, N. G., Leo, O., Wattiez, R., Figlewicz, D., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Rosa, A. L. (01 June 2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscular Disorders, 17 (8), 611-23. doi:10.1016/j.nmd.2007.04.002
Peer Reviewed verified by ORBi

Tassin, A., Ansseau, E., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Laoudj-Chenivesse, D., Oberdan, L., Coppée, F., & Belayew, A. (18 December 2006). Evidence for the expression of the DUX4 gene in primary myoblasts of patients affected with Facioscapulohumeral muscular dystrophy. Poster session presented at 194th Congrès de la Société Belge de Biochimie et de Biologie Moléculaire / 'Young Scientists Day, Gembloux, Belgium.

Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Sauvage, S., Barro, M., Tassin, A., Mattéotti, C., van Acker, A., Leroy, A., Leclercq, I., Leo, O., Figlewicz, D., Belayew, A., & Coppée, F. (2006). Characterization of the DUX4c gene located within a repeated element close to the FSHD locus. Paper presented at 11th International Congress of the World Muscle Society, Bruges, Belgium.

Ansseau, E., Tassin, A., Sauvage, S., Laoudj-Chenivesse, D., Barro, M., Figlewicz, D., Coppée, F., & Belayew, A. (09 October 2006). DUX4 gene expression in FSHD primary myoblasts. Paper presented at FSHD International Consortium Research Meeting, New Orleans, United States - Louisiana.

Ansseau, E., Coppée, F., & Belayew, A. (20 May 2006). Fonctional characterization of the DUX4 et DUX4c genes located within repeated elements at the FSHD locus. Poster session presented at Bioforum, Liège, Belgium.

Marcowycz, A., Mahieu, I., Tassin, A., Coppée, F., & Belayew, A. (17 May 2006). The DUX4 and DUX4c proteins, encoded by candidate genes for a muscular dystrophy (FSHD), have opposite functions in vivo. Poster session presented at Bioforum, Liège, Belgium.

Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Barro, M., Sauvage, S., Mattéotti, C., Mahieu, I., Tassin, A., Van Acker, A.-M., Leo, O., Fliglewicz, D., Coppée, F., & Belayew, A. (13 January 2006). Etude de DUX4 et DUX4c, gènes candidats pour la FSHD. Paper presented at Club muscle 'V', Paris, France.

Laumonier, C., Segers, J., Laurent, S., Michel, A., Coppée, F., Belayew, A., Vander Elst, L., & Muller, R. (01 January 2006). A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. Journal of Biomolecular Screening, 11 (5), 537-545. doi:10.1177/1087057106288220
Peer Reviewed verified by ORBi

Tassin, A., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Padberg, G. W., Oberdan, L., Coppée, F., & Belayew, A. (25 October 2005). Studies on the expression of the DUX4 and DUX4c proteins. Poster session presented at FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah.

Laoudj-Chenivesse, D., Barro, M., Sauvage, S., Tassin, A., Ansseau, E., Marcowycz, A., Figlewicz, D., Van Acker, A.-M., Leo, O., Belayew, A., & Coppée, F. (25 October 2005). Overexpression of the double homeodomain protein DUX4c in FSHD muscle. Paper presented at FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah.

Belayew, A., Ansseau, E., Sauvage, S., Marcowycz, A., Laoudj-Chenivesse, D., Carnac, G., Mattéotti, C., Gerbaux, C., Mahieu, I., Zorbo, S., Leclercq, I., Tassin, A., Figlewicz, D., & Coppée, F. (09 June 2005). Etude fonctionnelle de DUX4 et DUX4c, et de leur rôle dans la dystrophie de Landouzy-Dejerine. Paper presented at Meeting « Club Muscle IV », Marseille, France.

Ansseau, E., Sauvage, S., Laoudj-Chenivesse, D., Carnac, G., Marcowyzc, A., Leroy, A., Leclercq, I., Figlewicz, D., Belayew, A., & Coppée, F. (27 May 2005). Characterization of DUX4c, a double homeobox gene located in a truncated and inverted D4Z4 element, and its expression in FSHD mlyoblasts. Poster session presented at 190th meeting of the Belgian Society of Biochemistry and Molecular Biology, Mons, Belgium.

Ansseau, E., Sauvage, S., Laoudj-Chenivesse, D., Carnac, G., Marcowycz, A., Leroy, A., Leclercq, I., Figlewicz, D., Belayew, A., & Coppée, F. (09 May 2005). Characterization of DUX4c, a double homeobox gene located in a truncated and inverted D4Z4 element, and its expression in FSHD mlyoblasts. Poster session presented at Congrès Myologie 2005, Nantes, France.

Ansseau, E., Coppée, F., D'Amico, E., Marcowycz, A., Mattéotti, C., Sauvage, S., Wiilocq, J., & Belayew, A. (26 October 2004). Functional study of the DUX4 and DUX4c genes. Paper presented at FSHD International Consortium Research Meeting, Toronto, Canada.

Coppée, F., Mattéotti, C., Ansseau, E., Sauvage, S., Leclercq, I., Leroy, A., Marcowyzc, A., Gerbaux, C., Figlewicz, D., Ding, H., & Belayew, A. (2004). The DUX gene family and FSHD. In Facioscapulohumeral Muscular Dystrophy: Clinical Medicine and Molecular Biology (pp. 117-134). Bios. Scientific publisher.

Ansseau, E., Coppée, F., & Belayew, A. (2003). Publication of a sequence in GeneBank 'accession num. EMBL/Genbank: AY500824 :Homo sapiens double homeobox4c (DUX4c) gene, complete cds'.

Marcowyzc, A., Ansseau, E., Sauvage, S., Mattéotti, C., Zorbo, S., Belayew, A., & Coppée, F. (04 November 2003). Characterization of DUX4c and its role in facioscapulohumeral dystrophy (FSHD). Poster session presented at FSHD International Consortium Research Meeting, Los Angeles, United States.

Ansseau, E., Coppée, F., & Belayew, A. (01 October 2003). Etude de l'élément cis répresseur du locus D4Z4 et de son rôle dans l'expression de DUX4, un gène candidat pour la dystrophie facio-scapulo-humérale (FSHD). Poster session presented at 1ère journées annuelles de Société Française de Myologie, Caen, France.

Marcowycz, A., Ansseau, E., Coppée, F., & Belayew, A. (01 October 2003). Caractérisation du gène et de la protéine DUX4c. Paper presented at 1ère journées annuelles de la société française de Myologie, Caen, France.

Ansseau, E., Sauvage, S., Mattéotti, C., Marcowyzc, A., Belayew, A., & Coppée, F. (30 September 2003). Functional study of the DUX4 gene. Poster session presented at FSHD International Consortium Research Meeting, Los Angeles, United States.

Gerard, A.-C., Denef, J.-F., Many, M.-C., Gathy, P., de Burbure, C., van den Hove, M.-F., Coppée, F., Ledent, C., & Colin, I.-M. (01 May 2003). Relationships between cell division, expression of growth factors and microcirculation in the thyroids of Tg-A2aR transgenic mice and patients with Graves' disease. Journal of Endocrinology, 177, 269-277.
Peer Reviewed verified by ORBi

Coppée, F., Ledent, C., Clement, S., Dessars, B., Goffart, J. C., Parma, J., Parmentier, M., Schurmans, S., & Dumont, J. E. (1999). Transgenic models of thyroid tumorigenesis: relation to Chernobyl cancers. In Radiation and Thyroid Cancer (pp. 239-249). Word Scientific Publishing.

Seret, A., Schoutens, A., Blocklet, D., Moreno-Reyes, R., Coppée, F., Van Hove, C., & Defrise, M. (06 May 1999). Pinhole SPECT of small animals using vendor standard equipment. Paper presented at Symposium 'Frontiers in Nuclear Medecine Technology', Mol, Belgium.

Coppée, F., & Dessart, B. (25 September 1998). Expression of the cyclin-cdk complexes inhibitors (CKI) in proliferative thyroid pathologies of transgenic mice. Poster session presented at Hormones et régulation cellulaire, XXIIIe Symposium Européen du Mont Sainte-Odile, Sainte-Odile, France.

Coppée, F., Deporteere, F., Bartek, J., Ledent, C., Dumont, J. E., & Parmentier, M. (06 August 1998). Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Oncogene, 17, 631-641.
Peer Reviewed verified by ORBi

van den Hove, M.-F., Legssyer, R., Couvreur, M., Gerard, A.-C., Coppée, F., & Ledent, C. (22 March 1997). Thyroid expression of an A2 adenosine receptor induces iodine accumulation in light lysosomes. Paper presented at ECBO, Brighton , United States.

Uyttersprot, N., Allgeier, A., Baptist, M., Christophe, D., Coppée, F., Coulonval, K., Deleu, S., Depoortere, F., Dremier, S., Lamy, F., Ledent, C., Maenhaut, C., Miot, F., Panneels, V., Parma, J., Parmentier, M., Pirson, I., Pohl, V., Roger, P., & Dumont, J. E. (1997). The cAMP pathway in thyroid: from the TSH receptor to mitogenesis and tumorigenesis. Signal Transduction in Health and Disease, Advances in Second Messenger and Phosphoproteins Research. In Advances in Second Messenger and Phosphoproteins Research (pp. 125-140). Greengard & Nairn & Shenolikar & Corbin Francis.

Dremier, S., Coppée, F., Delange, F., Vassart, G., Dumont, J. E., & Van Sande, J. (01 December 1996). Thyroid autonomy: mechanism and clinical effects. Journal of Clinical Endocrinology and Metabolism, 81, 4187-4193.
Peer Reviewed verified by ORBi

Coppée, F. (13 November 1996). Apparition précoce de métastases différenciées à partir de carcinomes thyroïdiens chez des souris transgéniques exprimant le récepteur adénosine A2a et l'oncogène E7 de HPV16. Paper presented at Séminaire d'histologie, UCL, Bruxelles, Belgium.

Coppée, F., Gérard, A.-C., Denef, J.-F., Ledent, C., Vassart, G., Dumont, J. E., & Parmentier, M. (03 October 1996). Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene. Oncogene, 13, 1471-1482.
Peer Reviewed verified by ORBi

Dumont, J. E., Coulonval, K., Lamy, F., Van Sande, J., Parma, J., Dremier, S., Ledent, C., Coppée, F., & Savonet, V. (28 May 1996). Control of thyroid function and growth: cell division induced by cAMP is conditional on cell hypertrophy induced by IGF-1. Paper presented at 19th National Endocrinology Diabetes and Endocrine Surgery Congress, Istanbul, Turkey.

Ledent, C., Coppée, F., Dumont, J. E., Vassart, G., & Parmentier, M. (01 January 1996). Transgenic models for proliferative and hyperfunctional thyroid diseases. Experimental and Clinical Endocrinology and Diabetes, 104 (3), 43-46.
Peer Reviewed verified by ORBi

Dumont, J. E., Ermans, A. M., Maenhaut, C., Coppée, F., & Stanbury, J. B. (01 July 1995). Large goiter as a maladaptation to iodine deficiency. Clinical Endocrinology, 43 (1), 1-10.
Peer Reviewed verified by ORBi

Dumont, J. E., Ermans, A. M., Maenhaut, C., Coppée, F., & Stanbury, J. B. (01 July 1995). Large goitre as a maladaptation to iodine deficiency. Clinical Endocrinology, 43, 1-10.
Peer Reviewed verified by ORBi

Coppée, F. (01 February 1995). Caractérisation de souris transgéniques exprimant le récepteur adénosine A2a et l'oncogène E7 de HPV16 dans la thyroïde. Paper presented at Conférence Erasme, Bruxelles, Belgium.

Coppée, F., Ledent, C., Dumont, J. E., Vassart, G., & Parmentier, M. (21 January 1995). Coexpression of two oncogenes results in the development of transgenic model for metastatic differentiated thyroid carcinoma. Poster session presented at - Association Belge pour la recherche sur le cancer 'A.B.E.C.', Campus Erasme, ULB, Belgium.

Ledent, C., Coppée, F., & Parmentier, M. (01 September 1994). Transgenic models of metastatic differentiated thyroid carcinomas. Paper presented at European Thyroid Association, Vienne, Austria.

Ledent, C., Coppée, F., Dumont, J. E., Vassart, G., & Parmentier, M. (01 September 1994). Reconstruction of thyroid malignant phenotype in transgenic animals. Paper presented at European Thyroid Association, Vienne, Austria.

Contact ORBi